XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities:    
Net loss $ (3,571,929) $ (1,004,828)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 1,350,892 286,149
Depreciation and amortization 355,142 881
Changes in operating assets and liabilities:    
Prepayments and other current assets (378,506) 5,716
Accounts receivable (20,469) 0
Deferred cost (3,808) 0
Accounts payable 310,018 74,518
Deferred revenue 5,711 0
Accrued expenses 163,891 102,093
Net cash used in operating activities (1,789,058) (535,471)
Cash flows from investing activities:    
Note receivable (1,000,000) 0
Website development costs and other fixed assets (561,009) (432,419)
Net cash used in investing activities (1,561,009) (432,419)
Cash flows from financing activities:    
Proceeds from private placement of common stock 1,250,000 3,483,935
Net cash provided by financing activities 1,250,000 3,483,935
Net increase (decrease) in cash and restricted cash (2,100,067) 2,516,045
Cash and restricted cash at beginning of period 3,619,249 598,294
Cash and restricted cash at end of period 1,519,182 3,114,339
Supplemental disclosures of noncash investing and financing activities:    
Capitalization of stock-based compensation to website development costs 907,978 212,156
Accrual of stock issuance costs 381,895 363,219
Reclassification of Investor note payable to Common stock to be issued $ 3,000,000 $ 0